Less than half of the children aged 0-14 who have TB are diagnosed – so they never even start treatment.
Academic rigor, journalistic flair
Articles on preventive therapy
Displaying all articles
The next step in HIV prevention — long-acting injectable pre-exposure prophylaxis (PrEP) — is not yet available in Canada, a year after its approval in the U.S.
Until vaccines that are capable of protecting all populations against TB are developed, treatment is the best option to preventing infection.
Top contributors
-
Clinical Ethics Fellow, Department of Family & Community Medicine, University of Toronto
-
Lead Senior Scientist, Aurum Institute
-
Associate Professor, Public Health & Social Policy; Special Advisor Health Research, Office of the Vice-President Research and Innovation, University of Victoria
-
Clinician-Scientist, St. Michael’s Hospital; Associate Professor, Faculty of Medicine, University of Toronto
-
Socio-behavioural Scientist and Senior Researcher, Stellenbosch University
